Lori Morton

Senior Vice President, Research · Regeneron Pharmaceuticals

Biopharmaceuticals

Lori Morton is senior vice president of research at Regeneron Pharmaceuticals. She joined in 2002 and established cardiovascular, renal and fibrosis research at the company. Her work spans antibody therapeutics and newer nucleotide and gene therapy approaches.

Last reviewed: Oct 21, 2026

Lori Morton

Senior Vice President, Research Regeneron Pharmaceuticals

Last Reviewed: October 21, 2026

Executive Summary

Lori Morton is senior vice president of research at Regeneron Pharmaceuticals. She joined in 2002 and established cardiovascular, renal and fibrosis research at the company. Her work spans antibody therapeutics and newer nucleotide and gene therapy approaches.

Career Highlights

  • Joined Regeneron in 2002.
  • Established cardiovascular, renal and fibrosis research at Regeneron.
  • Sponsors the Women in Industry, Science & Engineering at Regeneron employee resource group.

Professional Journey

Morton completed postdoctoral fellowships at Pfizer and Sloan Kettering Cancer Center before joining Regeneron in 2002.

At Regeneron, she established research in cardiovascular disease, renal disease and fibrosis. She has led discovery and development across disease areas, working with antibody therapeutics as well as nucleotide and gene therapy approaches.

She now serves as senior vice president of Research. Alongside her scientific leadership, she sponsors Women in Industry, Science & Engineering at Regeneron, the employee resource group known as WISER. That activity connects her research leadership with support for employees working in science and engineering.

Education

Morton earned a BS from Douglass College of Rutgers University and a PhD from the University of North Carolina at Chapel Hill.